期刊文献+

肝细胞癌中上皮间质转化及其相关信号通路的研究进展 被引量:1

Epithelial-mesenchymal transition and related signaling pathways in hepatocellular carcinoma
下载PDF
导出
摘要 肝细胞癌(hepatocellular carcinoma,HCC)是一种最常见的肝癌,世界上癌症相关死亡的第3大常见原因.尽管各种治疗手段已经用于处理该致死性疾病,HCC患者的预后仍然很不理想,术后5年生存率大约为30%.术后复发转移是HCC患者预后不良的主要因素,这一过程被认为依赖于非运动性上皮肿瘤细胞获得间质细胞特征,称为上皮间质转化(epithelial-mesenchymal transition,EMT),E M T已经被认为是导致H C C侵袭转移的主要因素之一.值得注意的是,越来越多的证据表明多个信号通路参与调节HCC的EMT进展,本文将对近年来HCC中EMT及其相关信号通路的研究进展进行简要综述. Hepatocellular carcinoma(HCC) is one of themost common forms of liver cancer and the third leading cause of cancer-related mortality in the world. Although numerous therapeutic strategies have been employed to treat this fatal disease, the prognosis of HCC patients remains dismal with a low 5-year survival rate of approximately 30%. Postoperative recurrence and metastasis of HCC are the leading cause of poor prognosis. Metastasis has been thought to rely on non-motile epithelial tumor cells acquiring characteristics of mesenchymal cells, which are more migratory. This change is known as the epithelial-to-mesenchymal transition(EMT). EMT has been considered one of the main reasons for the invasion and metastasis of HCC. Notably, increasing evidence indicates that several signaling pathways participate in the regulation of EMT in HCC. In the current review, we will discuss the current progress in research of EMT and its related signaling pathways in HCC.most common forms of liver cancer and the third leading cause of cancer-related mortality in the world.Although numerous therapeutic strategies have been employed to treat this fatal disease,the prognosis of HCC patients remains dismal with a low 5-year survival rate of approximately 30%.Postoperative recurrence and metastasis of HCC are the leading cause of poor prognosis.Metastasis has been thought to rely on non-motile epithelial tumor cells acquiring characteristics of mesenchymal cells,which are more migratory.This change is known as the epithelial-to-mesenchymal transition(EMT).EMT has been considered one of the main reasons for the invasion and metastasis of HCC.Notably,increasing evidence indicates that several signaling pathways participate in the regulation of EMT in HCC.In the current review,we will discuss the current progress in research of EMT and its related signaling pathways in HCC.
出处 《世界华人消化杂志》 CAS 2016年第14期2131-2142,共12页 World Chinese Journal of Digestology
基金 陕西省社会发展科技攻关基金资助项目 No.2015SF038~~
关键词 肝细胞癌 上皮间质转化 侵袭转移 信号通路 Hepatocellular carcinoma Epithelialmesenchymal transition Invasion and metastasis Signaling pathway
  • 相关文献

参考文献119

  • 1Forner A, Llovet JM, Bruix J. Hepatocellular carcinoma. Lancet 2012; 379:1245-1255 [PMID: 22353262 DOI: 10.1016/S0140-6736(11)61347-0].
  • 2Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362:1907-1917 [PMID: 14667750 DOI: 10.1016/S0140-6736(03)14964-1].
  • 3Bosch FX, Ribes J, Diaz M, C16ries R. Primary liver cancer: worldwide incidence and trends. Gastroenterology 2004; 127:S5-$S16 [PMID: 15508102].
  • 4Davis FM, Stewart TA, Thompson EW, Monteith GR. Targeting EMT in cancer: opportunities for pharmacological intervention. Trends Pharmacol Sci 2014; 35:479-488 [PMID: 25042456 DOI: 10.1016/j.tips.2014.06.006].
  • 5Thiery JP, Acloque H, Huang RY, Nieto MA. Epithelial-mesenchymal transitions in development and disease. Cell 2009; 139:871-890 [PMID: 19945376 DOI: 10.1016/j.cell.2009.11.007].
  • 6Lamouille S, Xu J, Derynck R. Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol 2014; 15:178-196 [PMID: 24556840 DOI: 10.1038/nrm3758].
  • 7Pinzani M. Epithelial-mesenchymal transition in chronic liver disease: fibrogenesis or escape from death? J Hepatol 2011; 55:459-465 [PMID: 21320559 DOI: 10.1016/j.jhep.2011.02.001].
  • 8Yang J, Weinberg RA. Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis. Dev Cell 2008; 14:818-829 [PMID: 18539112 DOI: 10.1016/j.devcel.2008.05.009].
  • 9Subramani R, Gonzalez E, Arumugam A, Nandy S, Gonzalez V, Mede/ J, Camacho F, Ortega A, Bonkoungou S, Narayan M, Dwivedi AK, Lakshmanaswamy R. Nimbolide inhibits pancreatic cancer growth and metastasis through ROS-mediated apoptosis and inhibition of epithelial-to-mesenchymal transition. Sci Rep 2016; 6:19819 [PMID: 26804739 DOI: 10.1038/srep19819].
  • 10Gao Y, Zhao Y, Zhang J, Lu Y, Liu X, Geng P, Huang B, Zhang Y, Lu J. The dual function of PRMT1 in modulating epithelial-mesenchymal transition and cellular senescence in breast cancer cells through regulation of ZEB1. Sci Rep 2016; 6: 19874 [PMID: 26813495 DOh 10.1038/srep19874].

同被引文献5

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部